Keiretsu Forum MENA Partners with FinBursa to Bring AI-Native Deal Infrastructure to MENA’s Private Markets
Read More 1 minute read Business Accutar Biotechnology Announces First Patient Dosed in China with AC0682 in Phase 1 Study in ER-Positive Breast Cancer CRANBURY, N.J. & SHANGHAI — Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered… byKarrenOctober 12, 2022